Search

Your search keyword '"Garibaldi, E"' showing total 286 results

Search Constraints

Start Over You searched for: Author "Garibaldi, E" Remove constraint Author: "Garibaldi, E"
286 results on '"Garibaldi, E"'

Search Results

1. USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUB-REGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY

2. WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION

3. ASSOCIATION OF PERSISTENT URINARY SYMPTOMS WITH QUALITY OF LIFE AFTER PROSTATE CANCER RADIOTHERAPY

5. MO-0220 Two-year impact of bowel symptoms on HRQoL after RT for prostate cancer with pelvic node irradiation

6. PO-1483 Persistent urinary symptoms and long-term quality of life after prostate cancer radiotherapy

7. PD-01.48 - WORSENING OF 2-YEAR PATIENT-REPORTED INTESTINAL FUNCTIONALITY AFTER RADIOTHERAPY FOR PROSTATE CANCER INCLUDING PELVIC NODE IRRADIATION

9. CO-03.1 - USE DOSE OF SURFACE MAPS TO IDENTIFY BLADDER SUB-REGIONS ASSOCIATED WITH LATE TOXICITIES AFTER PROSTATE CANCER RADIOTHERAPY

11. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

12. Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)

13. OC-0457 Modeling outcome after salvage post-prostatectomy radiotherapy: impact of pelvic nodes irradiation

14. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer

15. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms

16. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

17. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

18. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

19. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

20. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT

21. PO-1363 Prediction of urinary toxicity after prostate cancer RT: long term evaluation

22. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer

23. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer

24. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer

29. PD-0059: Patient-reported baseline incontinence at post-prostatectomy RT: its dependence on time from surgery

30. PD-0668: Longitudinal analysis of patient-reported urinary incontinence 2yr after post-prostatectomy RT

31. PH-0366: Predictors of incontinence 2yr after post-prostatectomy RT: evidence of dose & fractionation effects

32. PO-1192: Elective Pelvic Nodes Irradiation in Patients with Prostate Cancer (PRO-EPI Study)

34. PO-0837 Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients

35. PO-0850 Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT

36. EP-1567 Prospective longitudinal evaluation of quality of life after prostate cancer IMRT

37. PO-0851 Quality of life after whole pelvis RT for prostate cancer: results from a prospective study

38. Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT)

39. Dose-effect relationship for 1-year incontinence after post-prostatectomy intensity-modulated radiotherapy (MRT)

40. 47. Dependence from dose and fractionation of late severe urinary toxicities after radical radiotherapy for prostate cancer

41. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

42. Preoperative Radiation Therapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: A Multicentric Randomized Study

43. PV-0320: NTCP models of late severe urinary symptoms after radical IMRT for prostate cancer

44. PV-0627: Hematologic toxicity after whole-pelvis irradiation: results of a longitudinal observational study

45. PO-0820: The bowel syndrome after whole pelvis RT for prostate cancer: acute symptoms and quality of life

48. Quality of life in the first year after RT for prostate cancer: Results from a prospective observational trial

49. Self-reported urinary incontinence from radiotherapy in the treatment of prostate cancer: Effect of RT intent

50. Incidence of Late Severe Urinary Symptoms after Radical IMRT for Prostate Cancer: Effect of Bladder Doses and Hypofractionation

Catalog

Books, media, physical & digital resources